Present full data from the ZUMA-7 study
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 29 Jul 2021
- Due
- 31 Dec 2021
- Delivered
- by 31 Dec 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Full data will be presented later this year and discussions are underway with global regulatory authorities.”
What we found
Evidence strength A What the grades mean
Gilead presented the results from the ZUMA-7 trial at the American Society of Hematology 2021 meeting, which occurred within the 2021 calendar year.
-
A Gilead Sciences Inc. 8-K filed 2022-02-01
“Results from the landmark ZUMA-7 trial of Yescarta in second-line LBCL were highlighted in a plenary session, where data included 60% improvement in event-free survival” ✓ confirmed on the page
Market reaction: the shares moved -4.0% against the S&P 500 over the three sessions around the disclosure (31 Jan 2022 to 3 Feb 2022). What this measures
Checked 2 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Present
- Deliverable
- ZUMA-7 study data
- Language
- Firm (“will”, “on track to”)
- In the company’s control
- High
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Gilead Sciences Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-GILD-004202 · Corrections policy